AtaiBeckley (ATAI) Change in Acquisitions & Divestments (2022 - 2025)
AtaiBeckley's (ATAI) quarterly Change in Acquisitions & Divestments came in at -$11.1 million in Q3 2025, up 85.12% year-on-year from -$6.0 million in Q3 2024, and down 200.0% quarter-over-quarter from $11.1 million in Q2 2025.
AtaiBeckley (ATAI) Change in Acquisitions & Divestments (2022 - 2025) Analysis & Trends
AtaiBeckley has disclosed Change in Acquisitions & Divestments across 4 years of filings, most recently posting -$11.1 million for Q3 2025.
- Change in Acquisitions & Divestments for Q3 2025 came in at -$11.1 million, up 85.12% year-over-year; the trailing twelve-month figure through Sep 2025 was $11.3 million (down 82.05% YoY), and the FY2024 annual result was $65.6 million, down 52.83% from the prior year.
- Change in Acquisitions & Divestments came in at -$11.1 million for Q3 2025 at AtaiBeckley, down from $11.1 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $226.8 million in Q4 2022 to a low of -$74.3 million in Q3 2024.
- The 4-year median for Change in Acquisitions & Divestments is $17.7 million (2023), against an average of $39.2 million.
- Peak annual rise in Change in Acquisitions & Divestments reached 377.87% in 2024, while the deepest fall reached 179.8% in 2024.
- AtaiBeckley's Change in Acquisitions & Divestments stood at $226.8 million in 2022, then plunged by 96.2% to $8.6 million in 2023, then soared by 30.97% to $11.3 million in 2024, then tumbled by 197.95% to -$11.1 million in 2025.
- The last three Change in Acquisitions & Divestments figures came in at -$11.1 million (Q3 2025), $11.1 million (Q2 2025), and $11.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11.06 Mn |
| Sep 30, 2025 | -11.06 Mn |
| Jun 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | 11.06 Mn |
| Dec 31, 2024 | 11.29 Mn |
| Dec 31, 2024 | 11.29 Mn |
| Sep 30, 2024 | -74.35 Mn |
| Sep 30, 2024 | -74.35 Mn |
| Jun 30, 2024 | 84.78 Mn |
| Jun 30, 2024 | 84.78 Mn |
| Mar 31, 2024 | 43.84 Mn |
| Mar 31, 2024 | 43.84 Mn |
| Dec 31, 2023 | 8.62 Mn |
| Dec 31, 2023 | 8.62 Mn |
| Sep 30, 2023 | 93.16 Mn |
| Sep 30, 2023 | 93.16 Mn |
| Jun 30, 2023 | 17.74 Mn |
| Jun 30, 2023 | 17.74 Mn |
| Mar 31, 2023 | 19.46 Mn |
| Mar 31, 2023 | 19.46 Mn |